Authors: Chambers, CD Braddock, SR Briggs, GG Einarson, A Johnson, YR Miller, RK Polifka, JE Robinson, LK Stepanuk, K Jones, KL

Citation: Cd. Chambers et al., Postmarketing surveillance for human teratogenicity: A model approach, TERATOLOGY, 64(5), 2001, pp. 252-261

Authors: Adams, J Buttar, HS Chambers, C Collins, TFX Graham, JM Jones, KL Kweder, S Mitala, J Polifka, JE Schwetz, BA

Citation: J. Adams et al., Teratology society public affairs committee position paper: Thalidomide, TERATOLOGY, 62(3), 2000, pp. 172-173

Authors: Luderer, U Burgess, JL Polifka, JE Robertson, WO

Citation: U. Luderer et al., Calls on reproductive and developmental toxicants to a regional poison center, VET HUM TOX, 41(1), 1999, pp. 42-46

Authors: Polifka, JE Shepard, TH

Citation: Je. Polifka et Th. Shepard, To the editor, TERATOLOGY, 60(2), 1999, pp. 56-57

Authors: Brent, RL Shepard, TH Polifka, JE

Citation: Rl. Brent et al., Response to Dr. Rosenquist's comments pertaining to the paper by Andaloro et al. ('98) "Dextromethorphan and other N-methyl-D-aspartate receptor antagonists are teratogenic in the avian embryo model" and letters to the editor by Polifka JE and Shepard TH ('98) and Brent RL ('98), TERATOLOGY, 60(2), 1999, pp. 61-62

Authors: Polifka, JE Friedman, JM

Citation: Je. Polifka et Jm. Friedman, Clinical teratology: identifying teratogenic risks in humans, CLIN GENET, 56(6), 1999, pp. 409-420